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SVMPA is a mutant of Sindbis virus, selected for its ability to replicate in mycophenolic acid (MPA)-treated mosquito cells. SVMPA
has another phenotype: although able to replicate normally in primary cultures of chick embryo fibroblasts (CEF), its replication is
restricted in secondary cultures prepared from aged primary CEF cultures. The mutations responsible for these phenotypes
mapped to the region of the viral genome that codes for nsP1. We report here that SVMPA has yet another phenotype. Relative to
our standard Sindbis virus (SVSTD) from which it was derived, SVMPA shows an increased sensitivity to chick interferon, both crude
interferon prepared from virus-infected cells and recombinant interferon. Characterization of viral mutants obtained after site-
directed mutagenesis indicated that the same mutations responsible for the host restriction of SVMPA in secondary cultures of CEF






























Viruses of the genus alphavirus, family Togaviridae, of
hich Sindbis virus (SV) is the prototype, are enveloped
nd have a positive-strand nonsegmented RNA genome,
11,700 nucleotides in length. Two viral mRNAs are
ound in infected cells: the genome-size RNA, which is
ranslated into the four nonstructural (ns) proteins, nsP1
hrough nsP4, and a subgenomic RNA whose sequence
s colinear with the 39 one-third of the viral genome and
hat encodes the structural proteins, C, E1, and E2. Both
f these RNAs are polyadenylated and have a 59 type 0
ap (Dubin et al., 1977; Strauss and Strauss, 1994).
Most viruses that replicate in the cytoplasm and make
RNAs with 59 caps must encode the protein(s) needed
o synthesize the methylated cap structure. Classically
here are three steps in the formation of the 59 cap
tructure on cellular or viral mRNAs: (1) removal of the
erminal phosphate from the 59 triphosphate of the nas-
ent RNA, (2) transfer of the GMP moiety from GTP first
o a guanylyltransferase (GTase) protein and then by
eans of a 59—59 linkage to the 59 diphosphate of the
ascent RNA, and (3) transfer by a methyltransferase
MTase) of a methyl group from S-adenosylmethionine
AdoMet) to the 7 position of the guanine base in the
MP moiety transferred in step two (Banerjee, 1980;
human, 1995). In the case of the alphavirus RNAs,
owever, methylation of the guanine base occurs before
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228he guanosine nucleotide is transferred to the nascent
NA (Ahola and Ka¨a¨ria¨inen, 1995).
SVLM21 is a viral mutant, which in contrast to our stan-
ard SV (SVSTD), from which it was derived, is able to
eplicate in methionine-deprived Aedes albopictus mos-
uito cells (Durbin and Stollar, 1985). The basis of this
henotype is the synthesis of an altered MTase with an
ncreased affinity for AdoMet (Scheidel et al., 1989). The
apping of the mutations responsible for the SVLM21 phe-
otype to the nsP1 coding region enabled us to associ-
te the methyltransferase activity of SV with nsP1 (Mi et
l., 1989).
Mycophenolic acid (MPA) is an inhibitor of the enzyme,
nosine monophosphate dehydrogenase (IMPDH), the
irst enzyme in the pathway specific for the synthesis of
MP. Thus cells treated with MPA have decreased levels
f GTP (Smith et al., 1974). When we treated Sindbis-
irus-infected mosquito cells with MPA, viral replication
as inhibited (Malinoski and Stollar, 1981). However, by
erially passaging SV in the presence of MPA, we suc-
eeded in isolating a viral mutant, SVMPA, which is resis-
ant to MPA (Scheidel et al., 1987). We suggested that
VMPA might be resistant to MPA because it made a
Tase with an increased affinity for GTP that would thus
e able to function in cells with decreased levels of GTP.
ecause the mutations responsible for the MPA-resistant
henotype, like those responsible for the SVLM21 pheno-
ype, mapped to the sequence encoding nsP1 (Scheidel
nd Stollar, 1991), we suggested that the guanylyltrans-
erase activity necessary for cap formation, like the meth-
ltransferase, would also be associated with nsP1. Sub-




































229SVMPA SENSITIVE TO CHICK INTERFERONonen et al. (1994) provided experimental evidence that
uch was indeed the case.
Subsequently we described another phenotype that
as associated with SVMPA, namely that its replication
as restricted in secondary cultures of chick embryo
ibroblasts (CEF) prepared from aged primary cultures
Rosenblum et al., 1994). Although we had reported ear-
ier that SVMPA had three mutations in the nsP1 coding
egion that are predicted to result in amino acid changes,
e concluded from studies of a revertant of SVMPA, which
as no longer restricted in secondary cultures of CEF
ut remained resistant to MPA, that only two of the three
mino acid changes in SVMPA nsP1 (S23N and V302M)
ere needed for the MPA-resistant phenotype. However,
he third change, Q21K, along with the S23N change was
equired for the host restriction in the secondary CEF
ultures.
Bearing in mind the findings of Sekellick and Marcus
FIG. 1. Relative efficiency of plaquing of SVSTD, SVMPA, and SV LM21 in the
ultures of CEF in 60-mm plates were treated with the indicated amounts
ith ;150 pfu/plate of the indicated virus, and plaque formation was m
o IFN treatment gave 100% plaquing efficiency. Each value represents
5 2. The numbers of plaques in the untreated cultures were: SVSTD,1985) that the production of IFN in CEF cultures varied larkedly with the age of the cultures (e.g., that aged
ultures made much higher levels of IFN than younger
ultures), we wondered whether the host restriction of
VMPA might in some way be related to an increased
ensitivity to IFN. We report here that SVMPA was indeed
ore sensitive than SVSTD to both crude chick cell IFN
nd to recombinant chick IFN. Results of experiments
ith mutants produced by site-directed mutagenesis
uggest a correlation between the restriction of viral
eplication in the secondary cultures of CEF, and in-
reased sensitivity to IFN.
RESULTS
We began by testing the sensitivity of SVMPA to crude
hick IFN. Primary cultures of CEF in 60-mm plates were
reated overnight with varying amounts of IFN, then in-
ected with ;150 pfu of SVSTD, SVLM21, or SVMPA and over-
nce of various amounts of IFN. Monolayer cultures of 1-day-old primary
de chicken IFN. Eighteen hours later, the cell monolayers were infected
ed. The values represent the normalized efficiency of plaquing where
ean of duplicate or triplicate samples. SVSTD and SV MPA, n 5 3; SVLM21,
0; SVLM21, 91–123; SVMPA, 110–120.prese
of cru
onitor





















































230 ROSENBLUM AND STOLLARater, neutral red was added to the cultures, and the
laques were counted after another 2 h. As shown in Fig.
, plaque formation by SVMPA was more sensitive to IFN
han plaque formation by either SVSTD or SVLM21. Whereas
t required only ;40 units of the crude chick IFN to
educe the number of SVMPA plaques by 90%, about four
nd six times as much IFN were required, respectively, to
educe the number of SVSTD and SVLM21 plaques to a
imilar extent. Figure 2 shows that SVMPA was also more
ensitive than SVSTD to recombinant chick IFN.
As seen in Table 1, the increased sensitivity of SV to
rude chick IFN was also demonstrated by yield assay.
reatment of primary cultures of CEF with 150 units of
FN reduced the yield of SVMPA .700-fold but that of SVSTD
nly 60-fold.
Several viruses were generated by site-directed mu-
agenesis of pToto1101, a plasmid from which infectious
indbis virus RNA transcripts can be generated. SVa120/
127 contains the mutations (adenylate at positions 120
nd 127) required to produce the host range phenotype
FIG. 2. Relative plaquing efficiencies of SVSTD and SVMPA on CEF treated
ith recombinant chick IFN. The procedure was as described in Fig. 1
xcept that recombinant chick IFN was used. The experiment was done
wice and gave similar results. In this experiment, the numbers of plaques
n the untreated cultures were SVSTD, 115; SVMPA 156.f SVMPA, [see Table 2 for the amino acid substitutions atositions 21 and 23 of the nsP1 proteins encoded by the
arious SV mutants (Rosenblum et al., 1994)]. Figure 3
hows that whereas 125 units of crude chick IFN were
eeded to produce a 90% reduction in the number of
laques produced by SVTOTO (virus generated from un-
utagenized Toto1101), only 45 units of IFN were re-
uired to produce a similar reduction in the number of
Va120/a127 plaques.
In the next experiment, we tested the effect of recom-
inant chick IFN on SVg122/a127, SVa120/c122/a127, and
Va120/a127 (g, c, and a, respectively, in Fig. 4), viruses
ith mutations produced by site-directed mutagenesis.
n contrast to SVa120/a127, the first two of these mutants
o not encode the two amino acid changes (positions 21
nd 23) in nsP1 that were seen with SVMPA and are
equired for the host range phenotype; (Rosenblum et al.,
994). As shown, the sensitivity of SVa120/a127 to the
loned IFN was similar to that of SVMPA, whereas SVg122/
127 and SVa120/c122/a127 resembled SVSTD.
Human IFN-aA/D is a recombinant human alpha inter-
eron, the amino terminal portion of which is derived from
FN-aA and the carboxyl-terminal portion from aIFN-aD.
f special interest is the observation that human IFN-
A/D is active in rodent cells. Thus unlike either IFN-aA
r IFN-aD, IFN-aA/D was able to inhibit the replication of
SV in mouse L cells (Rehberg et al., 1982). To see
TABLE 1
Yield of Sindbis Virus from Primary CEF in the Presence











VSTD 1.8 3 10
10 c 2.9 3 108 62
VMPA 4.5 3 10
9 6.0 3 106 733
a Cells were infected at an m.o.i. of 5, washed three times with PBS,
nd refed with 2 ml of medium. Culture medium was harvested 8 h p.i.
nd assayed for infectious virus by plaque formation on CEF.
b 60 mm plates of 1 day primary CEF were treated with 150 units of
rude chicken interferon added 16 h before infection.
c pfu/ml.
TABLE 2
Amino Acids at Position 21 and 23 of nsP1




























































231SVMPA SENSITIVE TO CHICK INTERFERONhether SVMPA showed an increased sensitivity to IFN-
A/D, we carried out a yield reduction assay with mouse
cells that had been treated with varying amounts of the
FN-aA/D. The sensitivities of SVSTD and SVMPA to this IFN
ere similar (data not shown). Approximately 100 units of
FN was required, in each case, to give a 90% reduction
n virus yield. Thus the increased sensitivity of SVMPA to
FN appears to be species specific.
DISCUSSION
The results presented above indicate that relative to
VSTD or SVTOTO, SVMPA shows an increased sensitivity to
hick IFN. This increased sensitivity was observed both
o crude chick IFN and to recombinant chick IFN. Fur-
hermore SVa120/a127, which was generated by site-
irected mutagenesis and contains the mutations re-
uired for the host-range phenotype of SVMPA (these mu-
ations lead to amino acid changes at positions 21 and
3 of nsP1, see Table 2), also showed an increased
ensitivity to IFN; but how these changes in nsP1 lead to
n increased sensitivity to IFN is not clear. Nor is it clear
hether this change in sensitivity to IFN accounts for the
estricted replication of SVMPA in secondary cultures of
hick cells prepared from aged primary cultures. Our
indings thus raise the question not only of why SVMPA
hows an increased sensitivity to chick IFN, but also the
ore basic question as to how IFN inhibits the replica-
ion of SV.
FIG. 3. Relative efficiency of plaquing of SVTOTO and SVa120/a127 in t
ig. 1. Each value is the mean of three replicate samples. The numbersIt has been reported that treatment of cells with IFN fnhibited the cap methylation of certain viral mRNAs
ncluding those of vesicular stomatitis virus, reovirus,
nd vaccinia virus (Kroath et al., 1978; Desrosoiers and
engyel, 1979; de Ferra and Baglioni, 1983). Because the
V nsP1 protein is involved in the capping and methyl-
tion of the SV mRNAs, the finding that changes in the
sP1 protein can alter the sensitivity of SV to IFN, sug-
ests that IFN may, as with other viruses, also inhibit cap
ormation on the SV mRNAs.
Studies with an SV mutant, ts-11, the causal mutation
f which is in the nsP1-coding region, indicate that nsP1
s also required for the synthesis of minus strand viral
NA (Wang et al., 1991). Conceivably then, if the SVMPA
utations, which are also in nsP1, led to the increased
ynthesis of minus-strand RNA, this would result in in-
reased amounts of ds RNA, a form of RNA that activates
t least two IFN-inducible enzymes, PKR, and 2–5 A
ynthetase (Stark et al., 1998). The increased activity of
ne or both of these enzymes in the IFN-treated infected
ells might then increase the sensitivity of viral replica-
ion to IFN. Finally it is possible that any lesion that
educes the replication competence of a virus may also
ender it more sensitive to IFN. However, as seen in
able 1, the SVMPA mutations do not interfere with the
bility of SVMPA to grow to high titer in untreated cells. In
ummary, it is clear that we will not be able to explain the
ncreased sensitivity of SVMPA to IFN without more basic
nformation about the mechanisms whereby IFN inter-
ence of various amounts of IFN. The procedure was as described for







































































232 ROSENBLUM AND STOLLARThere have been relatively few reports of viral mutants
istinguished by an altered sensitivity to IFN. An inter-
eron-sensitive mutant, is-1, of mengovirus was de-
cribed, which in contrast to wild-type or is1 virus, does
ot cause CPE in mouse L cells pretreated with low
oncentrations of mouse IFN (Simon et al., 1976). Under
hese conditions the mutant virus produces a 100- to
000-fold lower yield than the wt virus. In the absence of
FN, the growth of the mutant virus is comparable with
hat of the wild type.
The basis of the interferon sensitivity of the mutant
engovirus is not completely clear. On the one hand, is-1
nduced high levels of interferon in interferon-primed
ouse L cells, whereas the is1 virus did not (Marcus et
l., 1981). However, this does not appear to account for
he increased sensitivity of is-1 to IFN in the G3 line of
ouse L cells in which most of the studies of this mutant
ave been carried out (Simon et al., 1984). On the other
and, it has also been reported that whereas is1 virus
FIG. 4. Relative plaquing efficiencies of SVSTD, SVMPA, and three other
V mutants on CEF treated with recombinant chick IFN. The procedure
as as described for Fig. 2. The experiment was done twice and gave
imilar results. In this experiment, the numbers of plaques in the
ntreated cultures were SVSTD, F, 200; SVMPA, 1, 148; SVa120/a127 (a),
, 112; SVa120/c122/a127 (c), 3, 104; SVg122/a127 (g), , 135.ontains an anti-IFN activity and also induces such an cctivity in infected cells, such an activity was lacking in
s-1 (King and Simon, 1993), the mutant virus, and in
s-1-infected cells. This anti-IFN activity was recognized
hen is1 rescued is-1 from mouse L cells that had been
reated with mouse IFN. It was also proposed by King
nd Simon that the anti-interferon activity just described
s associated with the pentameric subunits of the virus.
he lack of this anti-IFN activity in is-1 is another possi-
le explanation for its sensitivity to IFN.
Of clinical relevance is the apparent variation in the
ensitivity of hepatitis C virus (HCV) to IFN. Although type
IFN is used for treating individuals infected with HCV, it
s effective in curing the disease in only a fraction of such
ndividuals (Enomoto et al., 1995). Assuming that the
ailure of many patients to respond to IFN was due to the
esistance of their strains of virus to IFN, Enomoto et al.
haracterized resistant and sensitive strains of virus by
equence analysis. These studies indicated that ‘‘IFN-
ensitive HCV’’ contained amino acid changes in a 40-
mino-acid sequence of the HCV nonstructural protein,
S5A. This region was designated as an IFN-sensitivity-
etermining region (ISDR). Subsequently it was reported
hat the resistance of HCV to IFN was due to repression
f the PKR protein kinase by the NS5A protein (Gale et
l., 1997). A recent study, however, failed to confirm the
ssociation of changes in the ISDR of NS5A with sensi-
ivity or resistance of HCV to IFN (Duverlie et al., 1998).
Many viruses have evolved mechanisms to counter
he antiviral effects of IFN (Gale and Katze, 1998). The
oss of such a mechanism by a virus would render it IFN
ensitive. On the other hand, the treatment of a virus-
nfected individual with IFN would be expected to select
or strains of virus that are IFN resistant. The further
tudy of virus strains that vary in their sensitivity to IFN
hould improve our understanding of the interaction be-
ween a virus and its host cell. More importantly, it may




Primary cultures of CEF were prepared as described
y Rosenblum et al. (1994). SVSTD, SVLM21, and SVMPA have
ll been described elsewhere (Shenk and Stollar, 1973;
urbin and Stollar, 1985; Scheidel et al., 1987). SVa120/
127, SVg122/a127, and SVa120/c122/a127 are mutants of
V produced by site-directed mutagenesis (Rosenblum
t al., 1994). SVa120/a127 is restricted in the secondary
EF cultures, but the other two mutants are not. The
rocedure for plaque formation was basically as de-
cribed by Shenk et al. (1974).
nterferons
Crude chick IFN was obtained from 8-day-old primary











































233SVMPA SENSITIVE TO CHICK INTERFERONhe titration of IFN were as described by Sekellick and
arcus (1986). Recombinant chick IFN (Sekellick et al.,
994) was kindly provided by Dr. Phillip Marcus, and
uman IFN-aA/D (Rehberg et al., 1982) was obtained
rom BioSource International.
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